- Home
- NHS vs ELMD Comparison
NHS vs ELMD Comparison
Compare NHS & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHS
- ELMD
- Stock Information
- Founded
- NHS 2003
- ELMD 1992
- Country
- NHS United States
- ELMD United States
- Employees
- NHS N/A
- ELMD N/A
- Industry
- NHS Trusts Except Educational Religious and Charitable
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NHS Finance
- ELMD Health Care
- Exchange
- NHS Nasdaq
- ELMD Nasdaq
- Market Cap
- NHS 229.5M
- ELMD 206.5M
- IPO Year
- NHS N/A
- ELMD 2010
- Fundamental
- Price
- NHS $7.65
- ELMD $24.21
- Analyst Decision
- NHS
- ELMD Strong Buy
- Analyst Count
- NHS 0
- ELMD 2
- Target Price
- NHS N/A
- ELMD $35.50
- AVG Volume (30 Days)
- NHS 111.8K
- ELMD 103.0K
- Earning Date
- NHS 01-01-0001
- ELMD 11-11-2025
- Dividend Yield
- NHS 13.44%
- ELMD N/A
- EPS Growth
- NHS N/A
- ELMD 46.55
- EPS
- NHS N/A
- ELMD 0.85
- Revenue
- NHS N/A
- ELMD $64,000,000.00
- Revenue This Year
- NHS N/A
- ELMD $14.47
- Revenue Next Year
- NHS N/A
- ELMD $10.33
- P/E Ratio
- NHS N/A
- ELMD $28.80
- Revenue Growth
- NHS N/A
- ELMD 16.97
- 52 Week Low
- NHS $6.95
- ELMD $17.73
- 52 Week High
- NHS $9.17
- ELMD $35.56
- Technical
- Relative Strength Index (RSI)
- NHS 66.40
- ELMD 56.38
- Support Level
- NHS $7.56
- ELMD $23.75
- Resistance Level
- NHS $7.68
- ELMD $24.92
- Average True Range (ATR)
- NHS 0.06
- ELMD 1.16
- MACD
- NHS 0.02
- ELMD -0.11
- Stochastic Oscillator
- NHS 85.42
- ELMD 21.26
About NHS Neuberger Berman High Yield Strategies Fund
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.